Does Silicon Supplementation Bone Health Randomized Trial work?

Updated October 2026

Quick Answer

Silicon Supplementation Bone Health Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: OVCFs are associated with significant reductions in health-related quality of life, progressive spinal deformity, and increased mortality risk [,].

Key Takeaways

  • 01OVCFs are associated with significant reductions in health-related quality of life, progressive spinal deformity, and increased mortality risk [,]. [Gazzeri Roberto (2026)]
  • 02Moreover, OVCFs substantially increase the risk of subsequent vertebral fractures by up to fivefold, initiating a cascade of skeletal fragility that further worsens long-term prognosis [,]. [Gazzeri Roberto (2026)]
  • 037 8 9 10 11 12 13 14 15 Most OVCFs are initially managed conservatively, and current international guidelines recommend non-operative treatment for stable fractures without neurological compromise [,,]. [Gazzeri Roberto (2026)]
  • 041 2 3 4 5 6 Osteoporotic vertebral compression fractures (OVCFs) are the most common manifestation of osteoporotic skeletal disease and represent a major global public health burden []. [Gazzeri Roberto (2026)]
The current Migaku evidence database contains 2 reusable source documents for Silicon Supplementation Bone Health Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - OVCFs are associated with significant reductions in health-related quality of life, progressive spinal deformity, and increased mortality risk [,]. [Gazzeri Roberto (2026); evidence level 4] - Moreover, OVCFs substantially increase the risk of subsequent vertebral fractures by up to fivefold, initiating a cascade of skeletal fragility that further worsens long-term prognosis [,]. [Gazzeri Roberto (2026); evidence level 4] - 7 8 9 10 11 12 13 14 15 Most OVCFs are initially managed conservatively, and current international guidelines recommend non-operative treatment for stable fractures without neurological compromise [,,]. [Gazzeri Roberto (2026); evidence level 4] - 1 2 3 4 5 6 Osteoporotic vertebral compression fractures (OVCFs) are the most common manifestation of osteoporotic skeletal disease and represent a major global public health burden []. [Gazzeri Roberto (2026); evidence level 4] - Dietary silica intake enhances bone health by promoting calcium absorption and deposition, leading to increased bone mineral density and aiding in the prevention of osteoporosis []. [Chen Yong (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Oral Food Supplement with Bio-Activated Silicium and Vitamins D3 and K2 in the Conservative Management of Osteoporotic Vertebral Compression Fractures
  2. Dietary Silicon Supplementation Improves Egg Production Performance in Late-Phase Laying Hens: Roles of Antioxidant Capacity, Reproductive Hormones, and Serum Cu/Zn Regulation